featured-image

Everyone’s aware of the dangers of cigarette smoking and the health benefits that can be gained by quitting. Varenicline (sold as Chantix and Champix) is the for cigarette smoking cessation because it’s been shown to effectively prevent both short- and long-term relapse. But what if you want to quit e-cigarettes? E-cigarette use, or vaping, , especially among younger adults, as and research emerges about its effects on health.

However, there’s a concern among those wanting to quit vaping, or the medical professionals encouraging it, that traditionally used treatments like varenicline might not work. Now, the results of the first US trial using varenicline to aid in quitting e-cigarette use have shown that it can be effective. “People can get to very high levels of nicotine exposure with these e-cigarette products, and they can use them near constantly throughout the day,” said Lisa Fucito, director of the Tobacco Treatment Service at the Yale Cancer Center and Smilow Cancer Hospital and the study’s lead and corresponding author.



“So, the question we all have is, ‘Can any pharmacotherapy stand up to this challenge?’” Researchers from the Yale Cancer Center and the Medical University of South Carolina (MUSC) Hollings Cancer Center conducted the trial. Forty participants with an average age of 28 years who’d vaped exclusively every day for six months or more were randomly assigned to receive either eight weeks of varenicline or a placebo. Fifty percent of p.

Back to Health Page